Pancreatic Cancer Research

ResearcherNewcastle upon Tyne Hospitals NHS Foundation TrustActive in the last 2 years

Beate Haugk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0125-1023; OpenAlex author ID A5088054367. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
  2. Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenoc… Co-author DOI 10.1038/s41598-021-00652-5↗
  3. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin defini… First author DOI 10.1016/j.pan.2020.01.004↗
  4. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001689↗
  5. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1038/bjc.2016.264↗
  6. Keap1-Nrf2 signalling in pancreatic cancer. Co-author DOI 10.1016/j.biocel.2015.06.017↗
  7. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2011.12.020↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard Charnley · 5 shared papers, 2012–2020 · strength 0.38
  2. Stuart Michael Robinson · 3 shared papers, 2012–2020 · strength 0.25
  3. Derek Manas · 3 shared papers, 2012–2020 · strength 0.25
  4. Steven Alan White · 2 shared papers, 2012–2020 · strength 0.14
  5. Manu K. Nayar · 1 shared paper, 2021 · strength 0.13
  6. John Samuel Leeds · 1 shared paper, 2021 · strength 0.13
  7. Kofi W. Oppong · 1 shared paper, 2021 · strength 0.13
  8. Steve A. White · 1 shared paper, 2020 · strength 0.11
  9. John A. G. Moir · 1 shared paper, 2020 · strength 0.11
  10. James K. Pine · 1 shared paper, 2020 · strength 0.11
  11. Jelena Mann · 1 shared paper, 2020 · strength 0.11
  12. Alastair J. Hayes · 1 shared paper, 2015 · strength 0.07
  13. Sari F. Alhasan · 1 shared paper, 2016 · strength 0.05
  14. Helen Louise Reeves · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.